Rekvina Laboratories
VINRKLB •BSE

Rekvina Laboratories

₹49.860.00 (0.00%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
49.80
Today’s high
49.86
52 week low
6.75
52 week high
59.40
Open price
49.86
Previous close
49.86
Live volume
--
Lower circuit
48.87
Upper circuit
50.85

Fundamentals

Market Cap
₹55Cr
ROE
20.74%
P/E Ratio(TTM)
--
EPS(TTM)
-0.31
P/B Ratio
14.36
Dividend Yield
0.00%
Industry P/E
50.66
Book Value
3.47
Debt to Equity
-1.20
Face Value
5

Financial performance

Quarterly
Yearly
All Financials
JUN '26
₹0.67Cr
-6.94%
-₹0.12Cr
-100.00%
-2-1012
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue growthValue
3Y CAGR+593%
Profit growthValue
1Y (TTM)-67%
3Y CAGR-86%

About

Rekvina Laboratories Limited operates in the pharmaceutical sector, engaging in the production and sale of various pharma products. The company's stated vision is to emerge as a leading manufacturer of formulations in specific therapeutic categories. It positions itself as a quality producer of pharmaceutical formulations tailored to meet the unique needs of its customers. A key business service offered is contract research and manufacturing, providing support to other industry players. Strategically, the company concentrates on its core activities of manufacturing and marketing formulations to drive its business forward. For the last financial year, the company's revenue from operations was nil, which was attributed to a general slowdown in the economy.;
Founded in
1988
BSE symbol
526075

Shareholding pattern

Sep '25
Dec '25
Mar '26
Jun '26
Aug '26
Shareholder details

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹2,631.90
0.00 (--)
L
    H
    20,008.9429.515.94
    PfizerPFIZER
    ₹3,858.90
    0.00 (--)
    L
      H
      17,635.9823.994.2
      Natco PharmaNATCOPHARM
      ₹821.30
      0.00 (--)
      L
        H
        16,120.1014.081.54
        ₹999.30
        0.00 (--)
        L
          H
          15,940.3545.362.25
          2026
          13
          Aug
          Quarterly Result
          Release date
          21
          May
          Annual Result
          Release date
          6
          Feb
          Quarterly Result
          Release date
          2025
          14
          Nov
          Quarterly Result
          Release date
          12
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks